Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts emphasized the considerable legal obstacles the ...

Drugmakers Pfizer and Flynn Pharma have been ... so they were no longer subject to price regulations. Pfizer hiked the price of the drug between 780% and 1,600%, and also supplied the drug to ...

Sponsor Message Pfizer said modest price increases ... effects of laws and regulations on pharmaceuticals and public health. Sponsor Message For consumers that means a drug may cost them less ...

China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most ...

The order calls on the health department, led by Robert F. Kennedy Jr., to broker new price tags for drugs over the next month.

The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered ...

this new policy could increase the cost of manufacturing for Pfizer (even though most of their brand-name drugs for the US market are finished in the US or countries with strong regulations).

Pfizer Inc.'s stock has performed poorly despite massive COVID-19 earnings, trading at a 12-year low due to flawed M&A deals and high debt levels. The discontinuation of danuglipron, a potential ...